The scientific programme will include: ● three days of scientific presentations
● five plenary lectures of eminent international scientists
● five parallel sessions with ten keynotes, fifty oral/flash communications
● two poster sessions
● exhibition by companies working in the field

Book of Abstracts


Posters' List

Panel discussion on the Lafora rare disease

Social program: 11/09 20,00 WELCOME COCKTAIL
Università degli Studi di Bari, Palazzo del Prete

Basilica di San Nicola

13/09 20,30 SOCIAL DINNER
Sala Zonno

Accompanying person fee includes:
Welcome cocktail
Basilica di San Nicola concert
coffee break & light lunches served at the congress venue
we have prepared a list of excursions planned to make your stay in Bari as enjoyable as possible.

12/09 Bari Archeological Bari
A journey across centuries, from Roman to Reinassance time, that shows the millennial history of Bari through its architectonical and archeological rests.
We will start from the lost Byzantine walls then we will explore the Armenian and Jewish neighbourhoods of the town.
San Sabino’s Cathedral; visit to the archeological museum in the basement of the church, the beautiful Timoteo’s mosaic floor, what remains of a Roman domus and a complete Byzantine church.
Santa Maria del Buonconsiglio’s Church; visit of the IX - X cent. mosaic floor

13/09 Floral Bari
The walk in the most elegant Bari is characterized by lightness, decoration, floral games and the use of the most varied materials.
Margherita Theater, Diasparro Palace, Petruzzelli Theater; Palazzo Cutrignelli; Palazzo Gomes Palazzo Atti; Palazzo Scattarelli; Palazzo Mincuzzi; Palazzo Goccia del latte; Kursaal Santa Lucia Theater

Confirmed Invited Speakers


Prof. Jürgen Bajorath

Chair of Life Science Informatics University of Bonn (Germany)

“Exploring Molecular Promiscuity through Activity Data Analysis and Explainable Artificial Intelligence”

Prof. C. Oliver Kappe

Institute of Chemistry University of Graz (Austria)

“The Use of Continuous Processing for Synthesizing Active Pharmaceutical Ingredients”

Prof. Maria Duca

Institute of Chemistry of Nice Université Côte d'Azur, Nice (France)

“Innovative strategies to target non-coding RNAs with synthetic ligands”

Prof. Laura H. Heitman

Oncode Institute & Leiden Academic Centre for Drug Research (LACDR) Leiden University Leiden (The Netherlands)

“Targeting chemokine receptor CCR2 - From insurmountable antagonists to affinity-based probes.”

Prof. Vincenzo Summa

Department of Pharmacy University of Naples Federico II

“COVID-19 pandemic: what we learnt in antiviral drug discovery, successes and failures.”


Prof. Marco Mor

Dipartimento di Scienze degli Alimenti e del Farmaco Università degli Studi di Parma

“Computational approaches to the design of covalent drugs”

Prof. Sabrina Taliani

Department of Pharmacy University of Pisa

“Unleashing the potential of Translocator Protein as a therapeutic and diagnostic target: a successful medchem tail”

Prof. Andrea Cavalli

Department of Pharmacy and Biotechnology University of Bologna Istituto Italiano di Tecnologia

“Synthetic lethality for next generation precision oncology”

Prof. Paola Conti

Department of Pharmaceutical Sciences University of Milan

“A nature inspired approach to develop covalent enzyme inhibitors with anti-infective and anticancer activity”

Prof. Fabio Del Bello

School of Pharmacy University of Camerino

“Targeting dopamine D4 receptor as a thrilling challenge to explore new therapeutic opportunities”

Dr. Rita Scarpelli

Fondazione Istituto Italiano di Tecnologia (IIT) Genova

“Identification of ARN21641, an orally available and CNS penetrant Acid Ceramidase inhibitor with target engagement in mouse models of Gaucher and Krabbe diseases”

Prof. Sandro Cosconati

DiSTABiF, Università degli Studi della Campania "Luigi Vanvitelli"

“Development and hands-on application of PyRMD: a new AI-powered virtual screening tool”

Dr. Alessio Barilli

Aptuit, an Evotec Company, Verona

“The discovery of Potent and Selective Agonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 5: From HTS to Early Hit Validation”

Dr. Laura Scalvini

Dipartimento di Scienze degli Alimenti e del Farmaco Università degli Studi di Parma

“From the catalytic mechanism to the enzyme substrate selectivity: a study on N-acylethanolamine acid amidase”

Dr. Francesco Merlino

Dipartimento di Farmacia Università degli Studi di Napoli «Federico II»

“From Natural Resource to Preclinical Candidate: Our Experience with the Temporin-derived Peptide Antimicrobial Agents”